| SCB-2019 as COVID-19 Vaccine (NCT04405908) | Clover Biopharmaceuticals AUS Pty | 2020-06-19 |
| CAR-37 T Cells in Hematologic Malignancies (NCT04136275) | Marcela V. Maus, M.D.,Ph.D. | 2020-06-19 |
| Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 (NCT04101357) | BioNTech SE | 2020-06-19 |
| Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers (NCT04415671) | AdAlta Limited | 2020-06-19 |
| hCT-MSCs for COVID19 ARDS (NCT04399889) | Joanne Kurtzberg, MD | 2020-06-18 |
| Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation (NCT04294459) | Sanofi | 2020-06-18 |
| Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension (NCT05562362) | Travere Therapeutics, Inc. | 2020-06-18 |
| Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants (NCT04423744) | Bayer | 2020-06-18 |
| Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer (NCT04479306) | M.D. Anderson Cancer Center | 2020-06-18 |
| Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fasted Condition (NCT04438733) | The Affiliated Hospital of Qingdao University | 2020-06-18 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 (NCT04449276) | CureVac | 2020-06-18 |
| Testing the Safety of CB-5339 in Patients With Cancer (NCT04372641) | National Cancer Institute (NCI) | 2020-06-18 |
| HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma (NCT06184841) | Peking University Cancer Hospital & Institute | 2020-06-18 |
| Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2) (NCT03588715) | Luis Montaner | 2020-06-18 |
| A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia. (NCT04369391) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2020-06-18 |
| CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma (NCT04381741) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-06-18 |
| JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations (NCT04418167) | JS InnoPharm, LLC | 2020-06-18 |
| A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult Participants (NCT06418620) | Sanofi | 2020-06-18 |
| Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML (NCT04365179) | Immune System Key Ltd | 2020-06-18 |
| Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026) (NCT04303156) | Merck Sharp & Dohme LLC | 2020-06-18 |
| A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease (NCT04220632) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-06-18 |
| Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery (NCT04420689) | Alume Biosciences, Inc. | 2020-06-18 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants (NCT04472832) | Agios Pharmaceuticals, Inc. | 2020-06-17 |
| A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours (NCT04414150) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-17 |
| Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome (NCT04447833) | Uppsala University | 2020-06-17 |
| An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 (NCT04437875) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-06-17 |
| An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol (NCT05874336) | Galmed Pharmaceuticals Ltd | 2020-06-17 |
| Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults (NCT04445389) | Genexine, Inc. | 2020-06-17 |
| Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer (NCT03939897) | National Cancer Institute (NCI) | 2020-06-17 |
| Bioequivalence Study of Coated Cesol Tablet Formulation Versus Biltricide (NCT04314037) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2020-06-17 |
| A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations (NCT04338711) | Pfizer | 2020-06-17 |
| An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19 (NCT04436471) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-06-17 |
| A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC) (NCT04438083) | CRISPR Therapeutics AG | 2020-06-16 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects (NCT04440345) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-06-16 |
| Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular Carcinoma (NCT04401813) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-06-16 |
| Topotecan Episcleral Plaque for Treatment of Retinoblastoma (NCT04428879) | The Hospital for Sick Children | 2020-06-16 |
| Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors (NCT04190628) | ABM Therapeutics Corporation | 2020-06-16 |
| Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers (NCT04779606) | Sintetica SA | 2020-06-16 |
| GT-032 Belapectin Hepatic Impairment (NCT04332432) | Galectin Therapeutics Inc. | 2020-06-16 |
| Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases (NCT04083183) | Fred Hutchinson Cancer Center | 2020-06-16 |
| Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors (NCT04169321) | Cytosite Biopharma Inc. | 2020-06-16 |
| Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus (NCT04345120) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2020-06-15 |
| Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia (NCT04040621) | Pfizer | 2020-06-15 |
| A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies (NCT04279405) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2020-06-15 |
| A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393) (NCT04431687) | Chong Kun Dang Pharmaceutical | 2020-06-15 |
| A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin Disease (NCT04269551) | Bioverativ, a Sanofi company | 2020-06-15 |
| Electrochemotherapy for Non-curable Gastric Cancer (NCT04139070) | Zealand University Hospital | 2020-06-15 |
| A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis (NCT04256174) | Akesobio Australia Pty Ltd | 2020-06-15 |
| The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole (NCT04676035) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-15 |
| Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma (NCT04323956) | Mayo Clinic | 2020-06-15 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes (NCT04465877) | Akros Pharma Inc. | 2020-06-15 |
| A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer (NCT04282031) | Beta Pharma (Suzhou) Co., Ltd. | 2020-06-15 |
| Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation (NCT04310579) | Food and Drug Administration (FDA) | 2020-06-15 |
| A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML (NCT05933070) | Inmune Bio, Inc. | 2020-06-15 |
| A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS. (NCT04355845) | Pfizer | 2020-06-15 |
| NasoShield in Healthy Adults to Study Safety and Immunogenicity (NCT04415749) | Altimmune, Inc. | 2020-06-15 |
| Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population (NCT02077010) | University of Kansas Medical Center | 2020-06-15 |
| SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis (NCT03783416) | Queen Mary University of London | 2020-06-15 |
| Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat (NCT04299633) | Akebia Therapeutics | 2020-06-15 |
| The Clinical Trial of ADR-001 for IgA Nephropathy (NCT04342325) | Nagoya University | 2020-06-15 |
| Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma (NCT04431635) | University of Michigan Rogel Cancer Center | 2020-06-15 |
| A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (NCT07435311) | R-Pharm | 2020-06-15 |
| A Study of LY3461767 in Healthy Participants (NCT04352114) | Eli Lilly and Company | 2020-06-15 |
| Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS (NCT05105685) | Affiliated Hospital of Jiangnan University | 2020-06-14 |
| Proof-of-concept Study of LUNA Intervention in Aphasia (NCT05847023) | City, University of London | 2020-06-14 |
| HDDO-1756 Bio Equivalence Study (NCT04755894) | Hyundai Pharmaceutical Co., LTD. | 2020-06-12 |
| HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia (NCT04424290) | Boehringer Ingelheim | 2020-06-12 |
| Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection (NCT04445038) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2020-06-12 |
| A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) (NCT04155580) | Astex Pharmaceuticals, Inc. | 2020-06-12 |
| Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection (NCT04445454) | University of Liege | 2020-06-12 |
| Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases (NCT04585724) | Emory University | 2020-06-12 |
| Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC (NCT04124991) | Seoul National University Hospital | 2020-06-12 |
| Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects (NCT07551713) | Haisco Pharmaceutical Group Co., Ltd. | 2020-06-11 |
| A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer (NCT04400188) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-11 |
| Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab (NCT04074967) | Dan Zandberg | 2020-06-11 |
| Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML (NCT04220684) | Sumithira Vasu | 2020-06-11 |
| Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease (NCT04206007) | Meridigen Biotech Co., Ltd. | 2020-06-11 |
| Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients (NCT04418401) | Zhejiang University | 2020-06-11 |
| A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder (NCT04398225) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2020-06-11 |
| A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma (NCT04106219) | Eli Lilly and Company | 2020-06-11 |
| Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects (NCT04423601) | Jiangsu HengRui Medicine Co., Ltd. | 2020-06-10 |
| NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (NCT04332653) | NeoImmuneTech | 2020-06-10 |
| Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties (NCT05675501) | Sol-Gel Technologies, Ltd. | 2020-06-10 |
| Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) (NCT03646188) | SkinJect, Inc. | 2020-06-10 |
| Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 (NCT04426695) | Regeneron Pharmaceuticals | 2020-06-10 |
| Lenalidomide in Combination With CHOP in Patients With Untreated PTCL (NCT04423926) | The First Affiliated Hospital with Nanjing Medical University | 2020-06-10 |
| A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors (NCT04408599) | NextCure, Inc. | 2020-06-10 |
| Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease (NCT04433104) | Vinmec Research Institute of Stem Cell and Gene Technology | 2020-06-09 |
| Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies (NCT04287868) | National Cancer Institute (NCI) | 2020-06-09 |
| 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) (NCT04517149) | 4D Molecular Therapeutics | 2020-06-09 |
| Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) (NCT04314089) | Edward Patz | 2020-06-09 |
| Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement (NCT04432714) | The First Affiliated Hospital with Nanjing Medical University | 2020-06-09 |
| Safety of TY027, a Treatment for COVID-19, in Humans (NCT04429529) | Tychan Pte Ltd. | 2020-06-09 |
| Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children (NCT04444284) | Meissa Vaccines, Inc. | 2020-06-09 |
| Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection (NCT04247282) | National Cancer Institute (NCI) | 2020-06-09 |
| A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets (NCT04420234) | First Affiliated Hospital of Zhejiang University | 2020-06-09 |
| Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced Malignancies (NCT04418661) | Sanofi | 2020-06-09 |
| Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal (NCT04470050) | BioXcel Therapeutics Inc | 2020-06-09 |
| Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects (NCT04309643) | Concert Pharmaceuticals | 2020-06-09 |
| Clinical Trial Intelligent Biometrics for PTSD - Clinical Trial (NCT04471207) | Medical University of South Carolina | 2020-06-08 |